Strategic Collaboration Boosts Cervical Cancer Prevention Efforts

Bajaj Finserv Health's Vidal Health and Serum Institute of India have joined forces to enhance cervical cancer prevention via a digital platform offering HPV vaccines. Starting October 2025, the platform will provide cashless vaccinations, digital appointments, and comprehensive program management, aiding national prevention and awareness initiatives.

Vidal Health, a part of Bajaj Finserv Health, alongside the Serum Institute of India, has announced a crucial partnership aimed at bolstering national endeavors to prevent cervical cancer.

Starting from October 2025, Vidal Health will introduce a cashless and seamless experience for accessing HPV vaccines through a digital platform, highlighted for its efficiency and end-to-end support, as revealed in their joint statement on Tuesday.

The initiative, anchored in technology, promises smooth access to high-quality HPV vaccines, with no middlemen involved, while ensuring timely dosage and compliance tracking, according to officials from Bajaj Finserv and SII.